// App-Quantinova.ai

BSH19‐EP‐065 : Dabigatran overdose requiring multiple doses of idaricuzimab; clinical and laboratory features

Researchers

Presenter

  • L. Nelmes

Principal Investigators

  • R. Chengal

  • D. White

  • S. Cox-Morton

  • M. Besser

  • W. Thomas

Medical Centers

  • Clinical School, University of Cambridge

  • Haematology, Cambridge University NHS Foundation Trust, Cambridge, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

  • Arrhythmia

Biomarkers

  • Activated partial thromboplastin time

Drug/Treatment

  • Idarucizumab

  • Perindopril

  • Pradax

  • Evithrom

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A